Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Giulia Salvatore is a leading clinical researcher in radiation oncology, with a focused expertise in breast cancer treatment and stereotactic radiosurgery. Her major contributions center on advancing preoperative partial breast irradiation (PBI) as a targeted, less invasive alternative to conventional postoperative radiotherapy. She is best known for her pivotal work as principal investigator of the phase II ROCK trial (NCT03520894), which demonstrated the safety and efficacy of preoperative robotic radiosurgery for early-stage breast cancer. This landmark study, published in 2022 and cited 29 times, established a new paradigm by treating a well-defined tumor target before surgery, potentially reducing toxicity and improving cosmetic outcomes. Dr. Salvatore’s research has significantly influenced clinical protocols, offering patients a more precise and patient-friendly approach to breast conservation. Her work bridges the gap between advanced radiation technology and practical oncology, earning her recognition as a key innovator in the field. With a growing citation impact, she continues to shape the future of breast cancer radiotherapy, inspiring both clinicians and researchers to explore preoperative strategies that prioritize both efficacy and quality of life.